Status:
TERMINATED
Evaluation of Gastric Residuals and Feedings Progression
Lead Sponsor:
Pontificia Universidad Catolica de Chile
Conditions:
Infant, Premature, Diseases
Nutrition, Enteral
Eligibility:
All Genders
1-48 years
Phase:
NA
Brief Summary
This study evaluates the utility of measuring gastric residuals in premature infants born between 26+0 and 33+6 weeks and to determine if its routine use is related with a delay in feedings advancemen...
Detailed Description
The evaluation of gastric residuals as a measure of enteral tolerance in term and especially preterm newborns is a widely used practice in different centers worldwide. However, until now, it continues...
Eligibility Criteria
Inclusion
- Preterm infants born between 26+0 to 33+6 weeks post-menstrual gestational age.
- Enteral feeds starting during the first week of life.
- Signed informed consent from parents or guardians.
Exclusion
- Perinatal asphyxia
- Sepsis and hemodynamic instability
- Major congenital malformations
- Surgical requirement during the first week of life
- Hemodynamic instability and vasoactive drugs requirement
- Moderate or severe respiratory failure with Oxygenation Index \> 8
Key Trial Info
Start Date :
October 14 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 31 2024
Estimated Enrollment :
203 Patients enrolled
Trial Details
Trial ID
NCT04064398
Start Date
October 14 2019
End Date
August 31 2024
Last Update
December 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pontificia Universidad Católica de Chile
Santiago, Santiago Metropolitan, Chile, 8330077